PPP2R1B and tongue squamous cell carcinoma: In tongue squamous cell carcinoma (TSCC), exosomal miR-200c may be an effective strategy for suppressing chemoresistance to docetaxel, as it inhibits TUBB3 and PPP2R1B [8].